title: Intravenous immunoglobulin: a safe option for treatment of steroid-resistant rejection in the presence of infection.
abstract: Management of recurrent allograft rejection is a risky proposition, especially in the presence of infections. Both steroids and antibody therapy worsen the infection risk. We successfully treated steroid-resistant rejection with intravenous immunoglobulin (IVIG) in two patients who had concomitant infections. IVIG should be considered the treatment of choice for management of steroid-resistant rejection in the presence of serious infection.
authors.affiliation: Department of Nephrology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
authors.forename: Venkatesh
authors.initials: V
authors.lastname: Moger
authors.forename: Machiraju S
authors.initials: MS
authors.lastname: Ravishankar
authors.forename: Vinay
authors.initials: V
authors.lastname: Sakhuja
authors.forename: Harbir S
authors.initials: HS
authors.lastname: Kohli
authors.forename: Kamal
authors.initials: K
authors.lastname: Sud
authors.forename: Krishan L
authors.initials: KL
authors.lastname: Gupta
authors.forename: Vivekanand
authors.initials: V
authors.lastname: Jha
mesh_terms: D000328:Adult; D003586:Cytomegalovirus Infections / Q000150:complications*; D004351:Drug Resistance; D004927:Escherichia coli Infections / Q000150:complications*; D006084:Graft Rejection / Q000150:complications / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous; D016030:Kidney Transplantation; D008297:Male; D013256:Steroids / Q000627:therapeutic use
chemical_list: D016756:Immunoglobulins, Intravenous; D013256:Steroids